Non-recurrence | Recurrence | p-value | |
---|---|---|---|
Male / Female (n) | 56 / 32 | 26 / 6 | 0.067 |
Age (years) | 68 ± 9 | 67 ± 10 | 0.691 |
Body weight (kg) | 58.8 ± 10.3 | 56.4 ± 9.2 | 0.217 |
pSize (mm) | 19.2 ± 5.7 | 24.2 ± 5.7 | < 0.001 |
3D-IRA at early phase (HU) | 36.7 ± 19.1 | 30.0 ± 14.6 | 0.046 |
Corrected 3D-IRA at early phase | 6.18 ± 3.25 | 4.94 ± 2.42 | 0.027 |
3D-IRA at delayed phase (HU) | 45.5 ± 15.7 | 40.6 ± 14.8 | 0.124 |
Corrected 3D-IRA at delayed phase | 7.63 ± 2.51 | 6.68 ± 2.37 | 0.059 |
Adenocarcinoma / SqCC / Others (n) | 58 / 22 / 8 | 19 / 9 / 4 | 0.772 |
Differentiation grade 1 / 2 / 3 / 4 (n) | 14 / 53 / 17 / 4 | 4 / 20 / 6 / 2 | 0.952 |
cStage IA / IB/ II-III (n) | 60 / 24 / 4 | 11 / 15 / 6 | 0.002 |
pStage IA / IB / II-III (n) | 51 / 24 / 13 | 7 / 5 / 20 | < 0.001 |
Lobectomy / Segmentectomy /WWR | 78 / 9 / 1 | 27 / 4 / 1 | 0.699 |
Adjuvant therapy none / Available (n) | 53 / 15 | 13 / 13 | 0.008 |